Notice
1 May 2025
regulatory compliance, business operations, fda, drug quality, outsourcing facilities, compounding
💊FDA Notice on Challenges for Compounding Outsourcing Facilities
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Learn More